p53 and poly(ADP-ribose) polymerase (PARP) are both DNA damage recognition proteins and can be functionally activated by DNA strand breaks. To understand the functional interaction between these two proteins, the eects of a PARP inhibitor, 3-aminobenzamide (3AB), on the p53 pathway were investigated in human glioblastoma cells with dierent p53 status. Consistent with previous studies, irradiation with g-rays induced both p53 and WAF1 accumulation in A-172 cells (wtp53) but not in T98G cells (mp53). However, the presence of 3AB but not its analog suppressed radiation-induced accumulation of wtp53 and the expression of WAF1 and MDM2. Similar results were also obtained from U87MG, another human glioblastoma cell line with wtp53 status. Northern blotting analysis showed that 3AB inhibited the g-ray-induced WAF1 gene expression. Moreover, 3AB but not its analog inhibited irradiationinduced activation of sequence-speci®c DNA binding of wtp53 as detected using 32 P-labeled or biotin-labeled p53 consensus sequence (p53CON). However, immunoblotting with an anti-poly(ADP-ribose) antibody showed that p53 proteins of the p53CON-bound fraction did not contain poly(ADP-ribose) (PAR). These ®ndings suggested that poly(ADP-ribosyl)ation is required for rapid accumulation of p53, activation of p53 sequence-speci®c DNA binding and its transcriptional activity after DNA damage.
Introduction
Accumulating evidence strongly supports the notion that the p53-mediated cellular response to genotoxic stress is a determinant for suppression of cancer events and maintenance of cellular homeostasis by inducing apoptosis or G 1 arrest (Donehower et al., 1992; Kastan et al., 1992; Yonish-Rouach et al., 1991; Lowe et al., 1993; Dulice et al., 1994) . As a stress signaler, how p53 activity is regulated in DNA-damaged cells has attracted a great deal of interest. Phosphorylation of p53 has been a major focus in this area and many phosphorylation sites on the p53 molecule have been de®ned, although the roles of each site in the regulation of p53 function in vivo have not yet been established (Fuchs et al., 1995; Milczarek et al., 1997; Hall et al., 1996; Wang et al., 1997a) . In contrast to phosphorylation, poly(ADP-ribosyl)ation is a unique post-translational modi®cation of nuclear proteins eected by poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30). After DNA strand breaks, this highly conserved nuclear enzyme is immediately activated and catalyzes the transfer of the ADP-ribose moiety from its substrate, nicotinamide adenine dinucleotide (NAD + ), to a number of acceptor proteins including PARP itself (for review, see de Mucia and Menissier de Murcia, 1994) . Although the biochemistry of this molecule has been studied in detail, its biological role is much less well clari®ed. Many contradictions remain to be resolved concerning both the role of PARP in DNA repair (de Murcia and Menissier de Murcia, 1994; Shall, 1994; Wang et al., 1995) and the mechanisms underlying cellular radiosensitization with alterations in PARP activity (Kupper et al., 1995; Van Gool et al., 1997) . We examined whether p53 function is modi®ed by poly(ADP-ribosyl)ation, as both p53 and PARP are involved in the immediate response to DNA damage. Using a speci®c inhibitor of PARP and its analog, we found evidence for the requirement of PARP activity to induce an intact p53 response after DNA damage, including rapid p53 accumulation, its enhanced sequence-speci®c DNA binding and transcriptional activation of its downstream genes.
Results

3AB but not its analog inhibited g-ray-activated poly(ADP-ribosyl)ation
We ®rst examined the spectrum of poly(ADPribosyl)ation after g-irradiation and the eects of 3AB and its analog. Treatment with these agents alone at 20 mM gave clonogenic survival rates of 85% and 100 % for A-172 and T98G cells, respectively, and showed no cytotoxic eects on either cell type throughout the treatment period of 36 h as determined by the trypan blue dye exclusion assay (data not shown). Whole cell lysates from A-172 cells were prepared 0.5 h or 1.5 h after g-irradiation. Western blotting analysis with a polyclonal anti-PAR antibody showed that there was a basal level of poly(ADPribosyl)ation in non-irradiated cells, and a signi®cant increase in poly(ADP-ribosyl)ation was observed 0.5 or 1.5 h after g-irradiation. However, the presence of 20 mM 3AB inhibited not only the g-ray-activated but also the basal poly(ADP-ribosyl)ation (Figure 1a ). It should be noted that species with molecular weights of 113 and 53 Kilodaltons (KD), which are possible positions of PARP and p53, exhibited signi®cant increases in poly(ADP-rybosyl)ation after g-irradiation. These increases were also completely suppressed by the presence of 20 mM 3AB but not its analog. On other hand, the total amount of PARP protein did not change after g-irradiation, and the heavily poly(ADPribosyl)ated PARP species was not detectable on immunoblotting using an anti-PARP antibody ( Figure  1b) . These results suggested that g-ray-activated poly(ADP-ribosyl)ation can be completely inhibited by the speci®c PARP inhibitor 3AB.
3AB suppressed wtp53 accumulation and WAF1 expression induced by irradiation
As a control experiment, activation of the p53 pathway by g-rays was ®rst examined in these two cell lines. As shown in Figure 2a , rapid and signi®cant accumulation of wtp53 occurred in A-172 cells, reaching a peak at 1.5 h after 3 Gy g-irradiation (10.7-fold as compared with non-treated control) and decreasing gradually thereafter (7.5-, 5.4-and 2.7-fold for 3, 6 and 10 h, respectively). In accordance with this, WAF1 expression also began to increase at 1.5 h (3.2-fold as compared with non-treated control) and it became signi®cant thereafter in A-172 cells (12.6-, 10.4-and 14.5-fold for 3, 6 and 10 h, respectively). In contrast, no accumulation of mp53 or WAF1 was observed in T98G cells at any time point after g-irradiation. These results indicated that 3 Gy g-irradiation activated the p53 pathway only in A-172 cells with the wtp53 status but not in T98G cells with the mp53 status.
When added to the cell cultures at 20 mM 2 h before irradiation, as shown in Figure 2b , wtp53 accumulation at 1.5 h after g-irradiation was signi®cantly suppressed by 3AB but not by its analog. The p53 amount of 3AB-treated cells at 1.5 h after g-irradiation was about 60% as compared with those of non-treated or analog-treated cells. However, this signi®cant suppression was not observed at 3 h after irradiation. In contrast, the level of mp53 in T98G cells was not aected by any treatment. Treatment with 3AB or its analog alone had no eect on the levels of either wtp53 or mp53. These Western blotting results indicated that 3AB aected the early phase of wtp53 accumulation induced by g-rays. To con®rm this suppression, the nuclear extracts from A-172 cells were examined at more time points after Xray irradiation. As shown in Figure 2c , analogtreated A-172 cells mounted an intact p53 response to 3 Gy X-irradiation with p53 peaking at 1.5 h and gradually decreasing thereafter. In contrast, 3AB-treated cells only accumulated p53 to an amount of about 50% of that in the analog-treated cells at 1.5 h. Although the analog-treated cells showed a p53 level similar to that of 3AB-treated cells at 3 h, they showed much higher p53 levels than 3AB-treated cells at later time points. In addition to its inhibitory eect on p53 accumulation induced by irradiation, 3AB but not its analog signi®cantly suppressed the gray-induced p53-dependent WAF1 or MDM2 expression in A-172 cells throughout the observation period of 24 h after irradiation ( Figure 2c ). The same experiment was performed with mp53 T98G cells but no 3AB-speci®c eects were observed on the p53 pathway (data not shown). To demonstrate that the eects of 3AB on the p53 pathway were not a cell type-dependent phenomenon, the same experiments were performed with another cell line with wtp53 status, U87MG. The results obtained at 6 h after Xirradiation were similar to those with A-172 cells. However, there was a second wave of p53 accumulation after 10 h only in 3AB-treated U87MG cells. The dierence in the second wave of p53 accumulation between analog-and 3AB-treated U87MG cells was most pronounced at 24 h at which time point a similar dierence was seen in WAF1 but not MDM2 expression ( Figure 2d ).
To demonstrate that the inhibitory eect of 3AB on radiation-induced WAF1 expression acts at the transcriptional level, Northern blotting was performed. As shown in Figure 3 , g-irradiation activated WAF1 gene expression only in A-172 cells (3.5-and 2.5-fold as compared to the non-treated control at 3 h and 6 h, respectively, after irradiation). The presence of 3AB but not its analog abolished the g-rayactivated WAF1 gene expression in A-172 cells (0.5-and 0.2-fold at 3 h and 6 h, respectively after irradiation). These results clearly indicated that blocking PARP activity with 3AB signi®cantly aected the activation of p53-dependent WAF1 expression by irradiation. Figure 3 Northern blotting analysis of WAF1 mRNA after 3 Gy of g-irradiation. 18S rRNA, Ethidium bromide staining of rRNA to control for equal loading. Other symbols are the same as in Figure 2 Figure 4 Eects of 3AB on p53 DNA binding activity detected by gel shift assay and Western blotting of the p53CON-bound p53. (a) Gel shift assay. Samples were nuclear extracts prepared 1 h after 3 Gy of g-irradiation. Aliquots of 5 mg of nuclear extracts were used for each reaction. PAb421, an anti-p53 monoclonal antibody recognizing a C-terminal epitope of p53. Saos-2, p53-null human osteosarcoma cells irradiated by 3 Gy of g-rays, were used as a negative control for p53. (b) Gel shift assay. Samples were nuclear extracts of A-172 cells prepared 1 h after 3 Gy of X-irradiation. Aliquots of 30 mg or 10 mg of nuclear extracts were used per reaction in the absence (7PAb421) or presence of PAb421 (+PAb421). Cold p53CON or Cold AP1, 80-fold molar excess of unlabeled p53CON or AP1 added as speci®c or nonspeci®c competitor oligonucleotides. The position of the band corresponding to the speci®c p53-p53CON-PAb421 complex is indicated by an arrow. (c) Western blot of p53CON-bound p53. Samples were nuclear extracts of A-172 cells prepared at various times after 3 Gy of X-irradiation. After incubation of 300 mg of nuclear extracts with biotinylated p53CON, the p53CON-bound proteins were released by addition of SDS ± PAGE loading buer and subjected to Western blotting with an anti-p53 monoclonal antibody, DO-1. Other symbols are the same as in Figure 2 3AB but not its analog suppressed radiation-activated p53 sequence-speci®c DNA binding activity p53 transactivates its downstream genes through DNAbinding to a speci®c sequence located upstream of p53-targeted genes Kern et al., 1992) . To demonstrate the eects of blocking PARP activity with 3AB on p53 DNA binding activity, a gel mobility shift assay using p53CON as a probe was carried out. As shown in Figure 4a , although the p53 DNA binding activity in non-treated control A-172 cells was nearly undetectable even in the presence of PAb421, it was signi®cantly increased after g-irradiation (24-fold as compared with non-treated control). However, the addition of 3AB but not its analog suppressed the increase in p53 DNA binding activity in A-172 cells by 40% (14-fold as compared with non-treated control). In contrast to A-172 cells, the mp53 in T98G showed no DNA binding activity before or after g-irradiation, although the addition of 3AB slightly increased DNA binding activity of this p53 mutant. To observe the eect of 3AB on the increase in p53 DNA binding activity after irradiation excluding the eect of anti-p53 antibody (PAb421), Up to 30 mg of nuclear extract from X-irradiated A-172 cells was used for gel shift assay. As shown in Figure 4b , although results very similar to those with g-irradiated samples ( Figure 4a ) were obtained with 10 mg of nuclear extract in the presence of PAb421, no informative results were obtained without addition of PAb421 even with 30 mg of nuclear extract. To obtain conclusive evidence of the inhibitory eect of 3AB on p53 DNA binding activity, a new strategy using biotinylated p53CON was employed for further experiments. Aliquots of up to 300 mg of nuclear extract were incubated with biotinylated p53CON in vitro. The p53 pulled down by biotinylated p53CON together with streptavidincoated magnetic beads was analysed by Western blotting. As shown in Figure 4c , no p53 was detectable in non-irradiated A-172 cells. In contrast, at 1.5 h after exposure to 3 Gy X-rays in the presence of 20 mM analog, the amount of p53CON-bound p53 species was increased markedly. Fairly high levels of this DNA-binding active form p53 of were maintained until 10 h after irradiation. However, the addition of 3AB reduced the amount of DNA-binding active p53 to 10% at 1.5 h and about 30% at other time points after irradiation as compared with the corresponding analog-treated samples.
Discussion
The diversity of the p53-activating factors covering genotoxic stresses such as ionizing radiation, UV light and DNA-damaging chemicals (Kastan, et al., 1992; Lu and Lane, 1993) and non-genotoxic stresses such as heat shock, low pH, cold shock, low oxygen, depletion of growth factors or nucleotides (Ohnishi et al., 1996 Ohtsubo et al., 1997; Graeber et al., 1994; Yonish-Rouach et al., 1991; Linke et al., 1996) indicates a function for p53 as an integrator of stress signals in response to intracellular and extracellular stressful environments (Hall et al., 1996; Wang and Ohnishi, 1997) . This wide responsiveness and the two opposite biological endpoints of p53, with apoptosis leading to active cell death and G 1 arrest leading to cell survival under stressful conditions put p53 into the category of multifunctional stress proteins and indicate that it is a key player in maintenance of cellular and tissue homeostasis .
Studies of phosphorylation regulation of p53 in vivo have not always provided clear-cut results Fuchs et al., 1995; Wang et al., 1997a) . This may be a re¯ection of multiple modi®cation of p53 function by distinct pathways in vivo due to its role as a multiple stress integrator. In the present study, we demonstrated that the DNA strand break-activated enzyme PARP can also act as modi®er of the function of p53. Blocking of PARP activity with 3AB suppressed the g-ray-induced rapid wtp53 accumulation by 40% at 1.5 h post-irradiation in human glioblastoma A-172 cells (Figure 2b) , suggesting positive regulation of p53 level by PARP in DNAdamaged cells. Similar data were also obtained from another human glioblastoma cell line, U87MG cells, with wtp53 status (Figure 2d ). These results were consistent with previous observations using V79-derivative PARP-de®cient or PARP-null cells (Whitacre et al., 1995; Agarwal et al., 1997) . These results suggested that PARP is not essential for DNA damageinduced p53 accumulation but is required for an intact p53 response after DNA damage including rapid and higher magnitude of p53 accumulation.
In addition to its inhibitory eect on p53 level, 3AB severely inhibited the radiation-induced expression of the gene products downstream of p53, WAF1 (ElDeiry et al., 1993) and MDM2 (Juven et al., 1993) within the observation period of 24 h after irradiation. This suggested a decreased p53 transcriptional activity because the stress-induced WAF1 expression in A-172 cells has been demonstrated previously to be p53-dependent (Wang et al., 1997a; . The results of Northern blotting analysis supported this suggestion (Figure 3) . The 10 h delay of WAF1 expression and its appearance at 24 h after irradiation in 3AB-treated U87MG cells (Figure 2d ) recapitulated the observation with PARP-null MEFs, although the 12 h delay in adriamycin-induced WAF1 expression was suggested not to be signi®cant in a previous report (Agarwal et al., 1997) . Further evidence for the involvement of PARP in regulation of p53 function was provided by the results of gel mobility shift assay. 3AB suppressed the g-ray-activated p53 binding activity to p53CON by 40% as compared to the noninhibitor analog (Figure 4a and b) . Although at present, it is not clear whether the p53 modi®cation by PARP directly contributes to p53 sequence-speci®c DNA binding, we speculate that the remaining 60% of p53CON-bound p53 may be a PARP-independent species. Thus, the contribution of PARP to p53 sequence-speci®c DNA binding is very similar to the case of p53 accumulation ( Figure 2a) ; i.e. a positive but non-essential involvement. However, the remaining 60% of p53CON-bound p53 in the presence 3AB did not lead to corresponding signi®cant WAF1 expression after g-irradiation for at least 10 h. These results suggested that activation of p53 transcriptional activity may also require PARP activity. However, gel shift assay does not allow precise examination of the eect of 3AB on p53 DNA binding because the p53-p53CON complex is not detectable on a native gel unless PAb421 is added to release the negative eect of p53 carboxy-terminal on p53 sequence-speci®c DNA binding (Hupp et al., 1992; Halazonetis and Kandil, 1993) . To address this issue more speci®cally, we used biotinylated p53CON together with streptavidin-coated magnetic beads to quantify the p53 species that can bind p53CON before and after irradiation in the presence of 3AB or its analog. Our results indicated that irradiation markedly activates the sequencespeci®c DNA binding of endogenous p53 in vivo, excluding the eects of addition of antibody. Furthermore, a more pronounced reduction by 3AB of p53 DNA binding was revealed by this new strategy as compared with gel shift assay (Figure 4a ± c) . Nevertheless, some p53 still bound p53CON in the 3AB-treated cells which we assumed to be a PARPindependent species.
We performed experiments to con®rm whether the p53 molecule is a receptor of PAR as suggested by an in vitro observation (Wesierska-Gadek et al., 1996) . The immunoblotting analysis using whole cell lysates with an anti-PAR antibody indicated basal in vivo activity of PARP independent of the presence of DNA breaks as previously observed in vitro (Simonin et al., 1993) , because positive PAR-staining was obvious in non-irradiated control cells (Figure 1 ). This basal PARP activity is required for a basal level of cellular p53 content as observed in PARP-de®cient and PARPknockout cells (Whitacre et al., 1995; Agarwal et al., 1997) . The addition of 20 mM 3AB suppressed the gray-activated PARP activity to lower than the basal level. The changes after irradiation in poly(ADPribosyl)ation at the 113 KD and 53 KD positions were noticeable and these were suggested to be a consequence of PARP automodi®cation and poly(ADP-ribosyl)ation of p53, respectively ( Figure  1) . However, immunoblotting analysis of anti-p53 immunoprecipitates with an anti-PAR antibody did not indicate whether p53 molecules contained PAR before or after DNA damage due to the interference of IgG heavy chain in our immunoprecipitates. We then examined whether the p53 of the p53CON-bound fraction contained PAR. Immunoblotting of the p53 pulled down with biotinylated p53CON with an anti-PAR antibody indicated that the p53CON binding active form of p53 did not contain PAR or at most contained PAR at levels below the limits of detection of our method. Here, it should be noted that the turnover of PAR is within 1 min due to high activity of poly(ADP-ribose) glycohydrolase, which degrades protein-bound polymers down to the protein-proximal ADP-ribose residue (de Murcia and Menissier de Murcia, 1994) . Therefore, it is possible that p53CON-bound p53 species might have contained PAR before we could detect it. However, at present, the precise mechanisms by which PARP aects DNA damageinduced p53 accumulation, p53 sequence-speci®c DNA binding and its transcriptional activity are still elusive.
Based on these observations, we assume that p53 is directly modi®ed by PARP as observed in an in vitro study (Wesierska-Gadek et al., 1996) and hypothesize that PARP may regulate p53 function in a poly(ADPribosyl)ation degree-and/or site-speci®c manner. The length of PAR polymer and/or the PAR accepting site may separately aect p53 accumulation, DNA binding or transcriptional activity by in¯uencing the subsequent modi®cations of p53 such as by phosphorylation, because the amino acid residues serine/threonine of p53 are mainly modi®ed by protein kinases (Tanaka et al., 1995) , while glutamine and/or lysine are modi®ed by PARP and cysteine is probably modi®ed by the redox/repair enzyme Ref-1 (Jayaraman et al., 1997) . This hypothesis oers to resolve the apparent discrepancies between the previous observations. For example, either decreasing the PARP activity (Kupper et al., 1995; Ding and Smulson, 1994) or overexpressing PARP (Van Gool et al., 1997) to break down the normal level of PARP causes enhanced cell killing in response to DNA damage. This may be the result of inappropriate modi®cation of p53 by altered PARP activity leading to a delayed response of the p53 pathway as revealed in this study. It has been shown that WAF1 is a major mediator of p53-dependent G 1 arrest (Deng et al., 1995) , the cell cycle stage when DNA-dependent protein kinase that is required for repair of lethal damages of double strand breaks exhibits its highest activity (Lee, et al., 1997) . In addition, WAF1 can be a potent antagonist of p53-dependent apoptosis (Polyak et al., 1996; Gorospe et al., 1997) and apparently facilitates DNA repair (McDonald et al., 1996) . Thus, a delay in p53-dependent WAF1 induction may have potent deleterious consequences such as the loss of appropriately timed G 1 arrest, DNA repair and suppression of apoptosis. This may account to some extent for the cellular sensitization to DNA damage and the enhanced genomic instability by alteration of PARP (Ding and Smulson, 1994) . This hypothesis also oers an explanation for the dierential eects of PARP on cells in dierent cell cycle stages. The eect of PARP may be indistinguishable in growth-arrested cells because the basal WAF1 level in these cells is high at the time of irradiation and thus is not readily aected. Conversely, when the cells are in the growth phase, a rapid WAF1 increase from a very low basal level may be required to selectively inhibit the proliferating cell nuclear antigen (PCNA) and then stop DNA replication as suggested by an in vitro observation (Shivji et al., 1994) . This may be a way for WAF1 to protect cells from lethal DNA damage even without induction of discernible G 1 arrest, and this protective eect may be more pronounced for cells in S phase. In summary, the present results suggested that the function of p53 as a multiple stress integrator is not only regulated by phosphorylation and redox but also by poly(ADPribosyl)ation in DNA-damaged cells.
Materials and methods
Cell culture and reagents
Human glioblastoma A-172 cells and U87MG (provided by JCRB, Setagaya, Tokyo, Japan) bearing the wtp53 gene (Matsumoto et al., 1994) are competent both in activating the expression of a p53-dependent reporter gene and WAF1 (Jung et al., 1995) . T98G cells (provided by JCRB) bearing homologous mp53 have a single G to A transition in the third position of codon 237, resulting in a missense mutant of Met to Ile (Ullrich et al., 1992) . However, they remain competent in p53-independent WAF1 induction by alkylating reagent ACNU (Aoki et al., 1998) . A p53-null human osteosarcoma Saos-2 cell line (Diller et al., 1990) was also obtained from JCRB. These cells were cultured in DMEM containing 10% (v/v) fetal bovine serum, penicillin (50 U/ml), streptomycin (50 mg/ml) and kanamycin (50 mg/ml). 3-aminobenzamide (3AB) and its analog, p-aminobenzoic acid were obtained from Wako Pure Chemical Industries Ltd (Osaka, Japan). Monoclonal anti-human WAF1 (EA10), anti-human p53 (PAb421, DO-1) and anti-MDM2 (Ab-1) antibodies were obtained from Oncogene Science Inc. (Uniondale, NY, USA). Rabbit polyclonal antibodies against poly(ADPribose) polymerase (PARP) and poly(ADP-ribose) (PAR) were kind gifts from Dr K Yoshihara (Department of Biochemistry, Nara Medical University, Kashihara, Japan). HRP-conjugated anti-mouse IgG antibody was purchased from Zymed Labs. Inc. (San Francisco, CA TM was purchased from TaKaRa Shuzo Co., Ltd. (Ohtsu, Shiga, Japan). Double-stranded p53CON oligonucleotides were synthesized by Japan Bioservice (Niiza, Saitama, Japan). Poly(dI-dC)poly(dI-dC) was purchased from Pharmacia Biotech (Uppsala, Sweden). RIPA buer contained 50 mM Tris, pH 7.2, 150 mM NaCl, 1% (v/v) Nonidet P-40. 1% (w/v) Na-deoxycholate and 0.05% (w/v) SDS. TBE buer contained 0.089 M Tris-0.089 M boric acid-0.002 M EDTA.
Treatment procedure
3AB and its analog were dissolved directly into DMEM medium at ®nal concentration of 20 mM. The cells were plated 12 h before treatment. The normal medium was changed to pre-warmed 3AB-or its analog-containing medium 2 h before irradiation. Irradiation was done at room temperature on either a Theratron 60 (Atomic Energy of Canada Ltd., Ottawa, Canada) at 0.25 Gy/min for a total dose of 3 Gy g-rays or on a MBR-1520R (150 kV, 20 mA, HITACHI, Tokyo, Japan) for 3 Gy X-rays. After irradiation the cells were cultured at 378C in the presence of 3AB or its analog for various periods.
Western blot analysis
Whole cell lysates or nuclear extracts were loaded on an SDS-10% or 15% polyacrylamide gel (SDS ± PAGE) at 20 mg/well. Other details of the Western blotting procedure were as described previously (Ohnishi et al., 1996) except for one modi®cation where all the steps of immunostaining were carried out in a small box while shaking at 80 ± 100 r.p.m. for treatment steps or at 130 ± 140 r.p.m. for washing steps on a shaker (Eyela MMS-100, Tokyo Rikakika Co., Ltd, Tokyo, Japan). The p53 band of these two human glioblastoma cell lines appears on Western blot as a doublet of deferentially charged species (Ullrich et al., 1992) , separation of which may depend on antibodies and conditions of gel electrophoresis. The densities of the p53 or WAF1 bands were measured using a Macintosh (LC 475) computer with the public domain NIH Image program (written by Wayne Rasband at the US National Institutes of Health). The relative fold increase was normalized to the band density of non-treated control cells.
Northern blot analysis
Total cellular RNA was prepared using the RNAzol TM method according to the manufacturer's instructions. RNA was quanti®ed by spectrophotometric methods. Fifteen mg cellular RNA was used for Northern blot analysis. WAF1 mRNA was detected with a WAF1 cDNA probe cut from the plasmid 2D10-5. Ethidium bromide staining of 28S rRNA and 18S rRNA was used as an internal control to ensure equal loading. Other details of the Northern blotting procedure were as described previously (Ohnishi et al., 1996) .
Gel mobility shift assay
The p53 DNA-binding activity was measured by the gel mobility shift assay (GMSA) using a synthetic doublestranded p53CON (5'-GGACATGCCCGGGCATGTCC-3') oligonucleotide as a probe Funk et al., 1992) . A synthetic double-stranded oligonucleotide containing double AP1 binding sites (5'-TGACTCAGT-GACTCAG-3') (Angel, et al., 1987) was used as a nonspeci®c competitor sequence. The p53CON probe was labeled with [g-32 P]-ATP using Megalabel TM and then incubated at room temperature for 30 min with nuclear extracts (5 mg or 10 mg protein/1 ng probe) in a total reaction volume of 16 ml adjusted with binding buer in the presence or absence of a monoclonal anti-p53 antibody, PAb421. Poly(dI-dC):poly(dI-dC) (1 mg) and sonicated salmon sperm DNA (1 mg) were used as nonspeci®c competitor DNA. The binding reaction was terminated by addition of 4 ml 56dye solution (0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene cyanol, 5% (v/v) glycerol and 0.05 M EDTA). The electophoresis was run on a 4% native polyacrylamide gel in 0.56TBE buer at 150 volts for 2 h at room temperature. The radioactive signals were visualized with a Fujix BAS 5000 Imaging Analyzer (Fuji, Tokyo, Japan) and photographed on a Pictrography 3000 (Fuji, Tokyo, Japan) connected to the BAS 5000. Other details of the GMSA procedure were as described previously (Funk et al., 1992) .
In vitro p53 DNA binding assay Aliquots of 300 mg of nuclear protein were incubated with 600 ng 5'-biotinylated p53CON, 30 mg of sonicated salmon sperm DNA and 15 mg of Poly(dI-dC):poly(dI-dC) as nonspeci®c competitor DNA. The binding reaction was completed at room temperature for 1 h in a volume of 300 ml adjusted with binding buer. Then, 40 ml streptavidin-coated magnetic beads (BioMag 1 Streptavidin, PerSeptive Biosystems, Framingham, MA, USA) were added to each tube and kept at room temperature for 20 min to allow binding. With a magnetic separation unit, the beads were washed four times with 500 ml ice-cold binding buer at room temperature for 5 min. After completely removing the binding buer, the beads were suspended in 40 ml of SDS ± PAGE loading buer and heated at 958C for 5 min to dissociate the bound proteins from the 5'-biotinylated p53CON. Finally, the supernatants were divided into two halves and used for Western blotting analysis of p53 and poly(ADP-ribose).
Abbreviations wtp53, wild-type p53; mp53, mutant p53; DMEM, Dulbecco's Modi®ed Eagle's Medium; HRP, Horseradish peroxidase; BLAST, Blotting Ampli®cation System; PBS, phosphate-buered saline; SDS, sodium dodecyl sulfate; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl¯uoride; p53CON, p53 consensus sequence. PAR, poly(ADPribose)
